Bioforce Nanosciences Holdings Cash Flow Statement (2020-2026) | BFNH

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-127784.00-130435.00-133457.00-122781.00-115915.00-117733.00
Cash from Operations (Quarter)
-27706.00-8677.00-9043.00-32941.00-9624.00-16393.00-9431.00-23054.00-8645.00-7917.00-7086.00-17581.00-13392.00-15442.00-14835.00-15215.00-27893.00-11121.00-10921.007,088.00
Change in Working Capital
Change in Accured Expenses (Quarter)
-11161.00321,308.00-316027.00105,750.00-111663.00444.00-446.00105,750.00105,750.00-210823.00422,323.007,482.00-4702.00314,470.00105,750.0012,492.00199,008.00-209627.00419,928.00101,250.00
Financing Activities
Cash from Financing Activities (Quarter)
23,176.008,677.00-7157.0032,941.007,749.007,913.009,415.0023,006.008,613.007,949.007,038.0017,583.0013,419.0016,410.0014,062.0028,152.0014,999.0011,000.0010,923.00-1527.00
Additional items
Change in Cash (Quarter)
-4530.00-16200.00-8480.00-16.00-48.00-32.0032.00-48.002.0027.00968.00-773.0012,937.00-12894.00-121.002.005,561.00
Free Cash Flow (Quarter)
-27706.00-8677.00-9043.00-32941.00-9624.00-16393.00-9431.00-23054.00-8645.00-7917.00-7086.00-17581.00-13392.00-15442.00-14835.00-15215.00-27893.00-11121.00-10921.007,088.00
Net Cash Flow (Quarter)
-4530.00-16200.00-1875.00-8480.00-16.00-48.00-32.0032.00-48.002.0027.00968.00-773.0012,937.00-12894.00-121.002.005,561.00